ArticleBMC cancer2015

Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.

Dmitriy Smolensky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.